Radioactive main group and rare earth metals for imaging and therapy
TI Kostelnik, C Orvig - Chemical reviews, 2018 - ACS Publications
Radiometals possess an exceptional breadth of decay properties and have been applied to
medicine with great success for several decades. The majority of current clinical use …
medicine with great success for several decades. The majority of current clinical use …
Matching chelators to radiometals for radiopharmaceuticals
Radiometals comprise many useful radioactive isotopes of various metallic elements. When
properly harnessed, these have valuable emission properties that can be used for …
properly harnessed, these have valuable emission properties that can be used for …
Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease
TJ Wadas, EH Wong, GR Weisman… - Chemical …, 2010 - ACS Publications
Molecular imaging is the visualization, characterization, and measurement of biological
processes at the molecular and cellular levels in humans and other living systems …
processes at the molecular and cellular levels in humans and other living systems …
Molecular imaging of cancer with positron emission tomography
SS Gambhir - Nature Reviews Cancer, 2002 - nature.com
The imaging of specific molecular targets that are associated with cancer should allow
earlier diagnosis and better management of oncology patients. Positron emission …
earlier diagnosis and better management of oncology patients. Positron emission …
Radiometals for combined imaging and therapy
CS Cutler, HM Hennkens, N Sisay… - Chemical …, 2013 - ACS Publications
The use of radionuclides in medicine is based largely on the discoveries of two critical
concepts, the “tracer principle” and the “magic bullet”. In 1913, George de Hevesy …
concepts, the “tracer principle” and the “magic bullet”. In 1913, George de Hevesy …
The diagnosis and medical management of advanced neuroendocrine tumors
GA Kaltsas, GM Besser, AB Grossman - Endocrine reviews, 2004 - academic.oup.com
Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms that
originate from endocrine glands such as the pituitary, the parathyroids, and the …
originate from endocrine glands such as the pituitary, the parathyroids, and the …
Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research
CJ Anderson, R Ferdani - Cancer Biotherapy and …, 2009 - liebertpub.com
Summation Copper-64 (T1/2= 12.7 hours; β+, 0.653 MeV [17.8%]; β−, 0.579 MeV [38.4%])
has decay characteristics that allow for positron emission tomography (PET) imaging and …
has decay characteristics that allow for positron emission tomography (PET) imaging and …
Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis
Background—Macrophages participate centrally in atherosclerosis, and macrophage
markers (eg, CD68, MAC-3) correlate well with lesion severity and therapeutic modulation …
markers (eg, CD68, MAC-3) correlate well with lesion severity and therapeutic modulation …
A Perspective–can copper complexes be developed as a novel class of therapeutics?
Although copper–ligand complexes appear to be promising as a new class of therapeutics,
other than the family of copper (II) coordination compounds referred to as casiopeínas these …
other than the family of copper (II) coordination compounds referred to as casiopeínas these …
[HTML][HTML] Somatostatin receptor PET ligands-the next generation for clinical practice
Somatostatin receptors (SSTRs) are variably expressed by a variety of malignancies. Using
radiolabeled somatostatin analogs (SSAs), the presence of SSTRs on tumor cells may be …
radiolabeled somatostatin analogs (SSAs), the presence of SSTRs on tumor cells may be …